Introducing a new era of controlled-pore glass (CPG) solid supports designed to maximise efficiency and yields, enabling scalable, sustainable therapeutic oligo synthesis at lower costs.

NexGen Native CPG Manufacturing
| New processes better suited to scale-up allowing us to grow economically with customer demand, whilst reducing cost and environmental impact. |
Surface Area Normalised Loading (SANL) Optimisation
| Consistently increased yields. 15-30% increase in Net Full-Length Product (FLP) Yield for siRNA compared to existing products. |
Pore Size Optimisation
| Maximises synthesis scale in your asset. |
New Capping Process
|
Higher yield and purity. Increased stability to DMT loss. |

*Minimum average gains vs Incumbent Product (600 Å CPG, 80-90 mmol/g)
PrimeMax siRNA CPG is now available as ready-to-order catalogue products, offering convenient access to high-quality CPG for oligonucleotide synthesis.
| Product name | Catalogue number |
| rA (Bz), 2'-OMe PrimeMax siRNA CPG, 400 Å | BG8-9001-B |
| rC (Ac), 2'-OMe PrimeMax siRNA CPG, 400 Å | BG8-9002-B |
| rG (iBu), 2'-OMe PrimeMax siRNA CPG, 400 Å |
BG8-9003-B |
| rU 2'-OMe PrimeMax siRNA CPG, 400 Å | BG8-9004-B |
| dT PrimeMax siRNA CPG, 400 Å | BG8-9005-B |
| UnyLinker™ PrimeMax siRNA CPG, 400 Å | BG8-9006-B |
| 3'-PT-Amino-C6 PrimeMax siRNA CPG, 400 Å | BG8-9007-B |
PrimeMax CPG offers a range of custom options to meet the specific needs of your oligonucleotide synthesis projects.
With custom PrimeMax CPG, you can:
Select the optimal pore size for your oligonucleotide length and chemistry
Choose linker types and modifications to meet your project requirements
Access unique functionalizations for specialized applications
Receive products manufactured to the same high standards as our catalogue offerings
Our custom CPG solutions provide the flexibility, precision, and control needed for advanced oligonucleotide synthesis.
